{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:31:04Z","timestamp":1777501864785,"version":"3.51.4"},"reference-count":53,"publisher":"Wiley","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["physoc.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Physiology"],"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p>Heart failure with preserved ejection fraction (HFpEF) remains a major health concern with limited therapeutic options. Growing evidence supports the multiple benefits of ketones in heart disease, but their impact on HFpEF remains unknown. We investigated whether increasing ketones can help to manage HFpEF. Using the ZSF1 rat model of HFpEF, 16\u2010week\u2010old rats were randomly assigned to one of three subgroups: (i) control diet; (ii) ketogenic diet (KD); or (iii) control diet with added exogenous ketone salts (KS) in their drinking water for 10 weeks. We found that both KD and KS ameliorated the HFpEF phenotype by improving structural echocardiographic parameters, lowering glycaemia and lipid profiles, and reducing HFpEF\u2010related fibrosis and hypertrophy without impacting <jats:italic>in vivo<\/jats:italic> diastolic function. Nevertheless, <jats:italic>ex vivo<\/jats:italic> cardiomyocyte preparations showed improved calcium handling and myofilament relaxation, suggesting benefits at the cellular level. Interestingly, KD still proved effective, despite the potentially adverse increase in fat mass. There was decreased myofilament Ca<jats:sup>2+<\/jats:sup> sensitivity and normalized active and passive tension in both groups, especially KS. These results suggest that providing ketone through the diet or supplements could be a valuable strategy to complement HFpEF treatment. Given the well\u2010known challenges of implementing dietary changes, exogenous KS offer a more practical and effective option to achieve these benefits.\n<jats:boxed-text content-type=\"graphic\" position=\"anchor\"><jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/tjp16674-gra-0001-m.png\"><jats:alt-text>image<\/jats:alt-text><\/jats:graphic><\/jats:boxed-text><\/jats:p><\/jats:sec><jats:sec><jats:title>Key points<\/jats:title><jats:p><jats:list list-type=\"bullet\">\n<jats:list-item><jats:p>Ketogenic diet and ketone salts effectively reversed the cardiac structural impairments associated with the ZSF1 Obese heart failure with preserved ejection fraction (HFpEF) phenotype by ameliorating left ventricular mass.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Both treatments reduced fibrosis and hypertrophy, leading to improved or, in the case of ketone salts, even reversed cardiomyocyte contractile and relaxation performance.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Ketone salts also reversed HFpEF\u2010related cardiomyocyte stiffness and prevented a reduction in the development of maximum force.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Both treatments improved myofilament Ca<jats:sup>2+<\/jats:sup> sensitivity.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Both treatments also improved the metabolic profile, reducing hyperglycaemia, blood triglycerides and levels of NT\u2010proBNP, a well\u2010known biomarker of worsening heart failure.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p><\/jats:sec>","DOI":"10.1113\/jp288229","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T08:51:54Z","timestamp":1743843114000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ketogenic diet and ketone salts differentially improve cardiometabolic complications in an HFpEF rat model"],"prefix":"10.1113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-8378","authenticated-orcid":false,"given":"Alexandre","family":"Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8329-3758","authenticated-orcid":false,"given":"In\u00eas N.","family":"Alves","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-6149","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Mendes","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"given":"Daniela","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7986-2425","authenticated-orcid":false,"given":"Gl\u00f3ria","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"Cardiovascular Regeneration Program Centro Nacional de Investigaciones Cardiovasculares (CNIC)  Madrid Spain"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-8962","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Almeida\u2010Coelho","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-2315","authenticated-orcid":false,"given":"Diana","family":"Martins","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"given":"Isabel","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"given":"Alexandre","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0442-3947","authenticated-orcid":false,"given":"Carolina","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"given":"Sandra Marisa","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"given":"Jos\u00e9","family":"Sereno","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Coimbra  Coimbra Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-8618","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Coimbra  Coimbra Portugal"}]},{"given":"Ulrich","family":"Dischinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Diabetes University Hospital W\u00fcrzburg  W\u00fcrzburg Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-8447","authenticated-orcid":false,"given":"Henrique","family":"Gir\u00e3o","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Coimbra  Coimbra Portugal"}]},{"given":"Adelino F.","family":"Leite\u2010Moreira","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-7674","authenticated-orcid":false,"given":"Vasco","family":"Sequeira","sequence":"additional","affiliation":[{"name":"Department of Translational Science, DZHI Universit\u00e4tsklinikum W\u00fcrzburg  W\u00fcrzburg Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1937-3782","authenticated-orcid":false,"given":"In\u00eas","family":"Falc\u00e3o\u2010Pires","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine University of Porto  Porto Portugal"},{"name":"RISE\u2010Health, Faculty of Medicine University of Porto  Porto Portugal"}]}],"member":"311","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"10","key":"e_1_2_5_2_1","article-title":"Myosin\u2010inhibitor mavacamten acutely enhances cardiomyocyte diastolic compliance in heart failure with preserved ejection fraction","volume":"17","author":"Almeida\u2010Coelho J.","year":"2024","journal-title":"Circulation: Heart Failure"},{"issue":"12","key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure","volume":"63","author":"Ambrosy A. P.","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"e_1_2_5_4_1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3390\/nu12082459","article-title":"Exogenous ketone supplements improved motor performance in preclinical rodent models","volume":"12","author":"Ari C.","year":"2020","journal-title":"Nutrients"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphys.2017.00974","article-title":"Differences in exercise capacity and responses to training in 24 inbred mouse strains","volume":"8","author":"Avila J. J.","year":"2017","journal-title":"Frontiers in Physiology"},{"issue":"8","key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced Human heart failure","volume":"133","author":"Bedi K. C.","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"e_1_2_5_7_1","article-title":"Hungry hearts","volume":"11","author":"Bertero E.","year":"2018","journal-title":"Circulation: Heart Failure"},{"issue":"15","key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N\u2010terminal \u2013 pro\u2010brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt P.","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmet.2017.03.005","article-title":"FGF21 regulates metabolism through adipose\u2010dependent and \u2010independent mechanisms","volume":"25","author":"BonDurant L. D.","year":"2017","journal-title":"Cell Metabolism"},{"issue":"1","key":"e_1_2_5_10_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12986-017-0184-4","article-title":"Oral \u03b2\u2010hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats","volume":"14","author":"Caminhotto R. D. O.","year":"2017","journal-title":"Nutrition & Metabolism (London)"},{"issue":"18","key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","article-title":"Cardiac metabolism in HFpEF: From fuel to signalling","volume":"118","author":"Capone F.","year":"2023","journal-title":"Cardiovascular Research"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100933","article-title":"SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta\u2010analysis","volume":"36","author":"Cardoso R.","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"2","key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria\u2010inflammation circuit by \u03b2\u2010hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng Y.","year":"2021","journal-title":"Circulation Research"},{"issue":"1","key":"e_1_2_5_14_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10020-018-0005-x","article-title":"Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction","volume":"24","author":"Fillmore N.","year":"2018","journal-title":"Molecular Medicine"},{"issue":"11","key":"e_1_2_5_15_1","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a Fibroblast Growth Factor 21 (FGF21)\u2010resistant state","volume":"59","author":"Fisher ffolliott M.","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"e_1_2_5_16_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and ppar\u03b1 activation in man","volume":"8","author":"G\u00e4lman C.","year":"2008","journal-title":"Cell Metabolism"},{"key":"e_1_2_5_17_1","first-page":"1","article-title":"In vitro assessment of cardiac function using skinned cardiomyocytes","volume":"2020","author":"Gon\u00e7alves\u2010Rodrigues P.","year":"2020","journal-title":"Journal of Visualized Experiments: JoVE"},{"issue":"20","key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.124.069732","article-title":"Randomized crossover trial of 2\u2010week ketone ester treatment in patients with type 2 diabetes and heart failure with preserved ejection fraction","volume":"150","author":"Gopalasingam N.","year":"2024","journal-title":"Circulation"},{"issue":"8","key":"e_1_2_5_19_1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen A.","year":"2020","journal-title":"European Journal of Heart Failure"},{"issue":"9","key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary hypertension in HFpEF and HFrEF","volume":"76","author":"Guazzi M.","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"e_1_2_5_21_1","first-page":"1239","article-title":"Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model","volume":"6","author":"Hamdani N.","year":"2013","journal-title":"Circulation: Heart Failure"},{"issue":"6","key":"e_1_2_5_22_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/metabo11060397","article-title":"The effects of fasting or ketogenic diet on endurance exercise performance and metabolism in female mice","volume":"11","author":"Holcomb L. E.","year":"2021","journal-title":"Metabolites"},{"issue":"22","key":"e_1_2_5_23_1","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1161\/CIRCULATIONAHA.122.062021","article-title":"Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: The randomized, controlled EMPA\u2010VISION trial","volume":"147","author":"Hundertmark M. J.","year":"2023","journal-title":"Circulation"},{"key":"e_1_2_5_24_1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/DMSO.S292742","article-title":"Adherence to low\u2010carbohydrate diets in patients with diabetes: A narrative review","volume":"15","author":"Kumar N. K.","year":"2022","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"47","key":"e_1_2_5_25_1","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam C. S. P.","year":"2019","journal-title":"European Heart Journal"},{"issue":"7","key":"e_1_2_5_26_1","article-title":"Arterial remodeling and dysfunction in the ZSF1 rat model of heart failure with preserved ejection fraction","volume":"12","author":"Leite S.","year":"2019","journal-title":"Circulation: Heart Failure"},{"issue":"6","key":"e_1_2_5_27_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/10742484211034253","article-title":"Chronic sildenafil therapy in the ZSF1 obese rat model of metabolic syndrome and heart failure with preserved ejection fraction","volume":"26","author":"Leite S.","year":"2021","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"14","key":"e_1_2_5_28_1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024668","article-title":"Characteristics associated with Growth Differentiation Factor 15 in heart failure with preserved ejection fraction and the impact of pirfenidone","volume":"11","author":"Lewis G. A.","year":"2022","journal-title":"Journal of the American Heart Association"},{"issue":"156","key":"e_1_2_5_29_1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0009-2020","article-title":"BNP\/NT\u2010proBNP in pulmonary arterial hypertension: Time for point\u2010of\u2010care testing?","volume":"29","author":"Lewis R. A.","year":"2020","journal-title":"European Respiratory Review"},{"issue":"19","key":"e_1_2_5_30_1","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/ehp261","article-title":"Growth\u2010differentiation factor\u201015 is an independent marker of cardiovascular dysfunction and disease in the elderly: Results from the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) Study","volume":"30","author":"Lind L.","year":"2009","journal-title":"European Heart Journal"},{"issue":"4","key":"e_1_2_5_31_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real\u2010time quantitative PCR and the 2(\u2010Delta Delta C(T)) method","volume":"25","author":"Livak K. J.","year":"2001","journal-title":"Methods (San Diego, California)"},{"issue":"1","key":"e_1_2_5_32_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00125-022-05815-1","article-title":"Ketones: The double\u2010edged sword of SGLT2 inhibitors?","volume":"66","author":"Lupsa B. C.","year":"2023","journal-title":"Diabetologia"},{"issue":"4","key":"e_1_2_5_33_1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/nu15040927","article-title":"Ketogenic diet applied in weight reduction of overweight and obese individuals with progress prediction by use of the modified Wishnofsky equation","volume":"15","author":"Markovikj G.","year":"2023","journal-title":"Nutrients"},{"issue":"8","key":"e_1_2_5_34_1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/diab.46.8.1360","article-title":"Leptin directly alters lipid partitioning in skeletal muscle","volume":"46","author":"Muoio D. M.","year":"1997","journal-title":"Diabetes"},{"issue":"10","key":"e_1_2_5_35_1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s12325-019-01045-x","article-title":"Effect of empagliflozin on free fatty acids and ketone bodies in Japanese patients with type 2 diabetes mellitus: A randomized controlled trial","volume":"36","author":"Nishimura R.","year":"2019","journal-title":"Advances in Therapy"},{"issue":"5","key":"e_1_2_5_36_1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/15592294.2015.1024406","article-title":"HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes","volume":"10","author":"Ooi J. Y. Y.","year":"2015","journal-title":"Epigenetics"},{"issue":"4","key":"e_1_2_5_37_1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ejhf.1732","article-title":"Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium\u2013glucose cotransporter 2 inhibitors","volume":"22","author":"Packer M.","year":"2020","journal-title":"European Journal of Heart Failure"},{"issue":"4","key":"e_1_2_5_38_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus W. J.","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"e_1_2_5_39_1","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1125687","article-title":"Inflammation as a therapeutic target in heart failure with preserved ejection fraction","volume":"10","author":"Peh Z. H.","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"e_1_2_5_40_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","article-title":"Leptin as a key regulator of the adipose organ","volume":"23","author":"Pic\u00f3 C.","year":"2022","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"e_1_2_5_41_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.746494","article-title":"Inflammation in human heart failure: Major mediators and therapeutic targets","volume":"12","author":"Reina\u2010Couto M.","year":"2021","journal-title":"Frontiers in Physiology"},{"issue":"2","key":"e_1_2_5_42_1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jcmg.2020.07.042","article-title":"Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis\/stiffness in nondiabetic heart failure","volume":"14","author":"Santos\u2010Gallego C. G.","year":"2021","journal-title":"Journal of the American College of Cardiology Cardiovasc Imaging"},{"issue":"5","key":"e_1_2_5_43_1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/ehf2.12915","article-title":"ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction","volume":"7","author":"Schauer A.","year":"2020","journal-title":"European Society of Cardiology Heart Failure"},{"key":"e_1_2_5_44_1","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1008922","article-title":"Anti\u2010inflammatory role of SGLT2 inhibitors as part of their anti\u2010atherosclerotic activity: Data from basic science and clinical trials","volume":"9","author":"Scisciola L.","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"17","key":"e_1_2_5_45_1","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1113\/JP270354","article-title":"Synergistic role of ADP and Ca2+ in diastolic myocardial stiffness","volume":"593","author":"Sequeira V.","year":"2015","journal-title":"The Journal of Physiology"},{"issue":"12","key":"e_1_2_5_46_1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon S. D.","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_5_47_1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.802541","article-title":"The nuanced metabolic functions of endogenous FGF21 depend on the nature of the stimulus, tissue source, and experimental model","volume":"12","author":"Spann R. A.","year":"2022","journal-title":"Frontiers in Endocrinology"},{"issue":"8","key":"e_1_2_5_48_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231234","article-title":"The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15","volume":"15","author":"Stolina M.","year":"2020","journal-title":"PLoS ONE"},{"issue":"4","key":"e_1_2_5_49_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvae006","article-title":"Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction","volume":"120","author":"Sun Q.","year":"2024","journal-title":"Cardiovascular Research"},{"issue":"2","key":"e_1_2_5_50_1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/advances\/nmaa130","article-title":"Perspective: Ketone supplementation in sports\u2014Does it work?","volume":"12","author":"Valenzuela P. L.","year":"2021","journal-title":"Advances in Nutrition"},{"issue":"20","key":"e_1_2_5_51_1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/eurheartj\/ehab911","article-title":"Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality","volume":"43","author":"Verbrugge F. H.","year":"2022","journal-title":"European Heart Journal"},{"issue":"1","key":"e_1_2_5_52_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3988\/jcn.2015.11.1.26","article-title":"Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: A meta\u2010analysis","volume":"11","author":"Ye F.","year":"2015","journal-title":"Journal of Clinical Neurology"},{"issue":"1","key":"e_1_2_5_53_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-nutr-070208-114232","article-title":"Nonalcoholic fatty liver disease and low\u2010carbohydrate diets","volume":"29","author":"York L. W.","year":"2009","journal-title":"Annual Review of Nutrition"},{"issue":"13","key":"e_1_2_5_54_1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.12.065","article-title":"Therapeutic potential of ketone bodies for patients with cardiovascular disease: JACC state\u2010of\u2010the\u2010art review","volume":"77","author":"Yurista S. R.","year":"2021","journal-title":"Journal of the American College of Cardiology"}],"container-title":["The Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/pdf\/10.1113\/JP288229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T08:54:24Z","timestamp":1743843264000},"score":1,"resource":{"primary":{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/10.1113\/JP288229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":53,"alternative-id":["10.1113\/JP288229"],"URL":"https:\/\/doi.org\/10.1113\/jp288229","archive":["Portico"],"relation":{},"ISSN":["0022-3751","1469-7793"],"issn-type":[{"value":"0022-3751","type":"print"},{"value":"1469-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"2024-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"JP288229"}}